W103f - Panel Questions – Applying Patient-centric Quality Standards Concepts

Chair(s):

• Seán Barry, HPRA-Health Products Regulatory Authority
• Teresa Pepper, BioMarin U.K. Ltd.

Panelist(s):

• Anthony Mire-Sluis, AstraZeneca
• Barbara Rellahan, Amgen Inc.
• Matthew Roberts, GlaxoSmithKline
• Kenneth Riker, Juno Therapeutics, A Bristol-Myers Squibb Company
• Mats Welin, Swedish Medical Products Agency
• Susan Kirshner, CDER, FDA
• Brigitte Brake, BfArM- Federal Institute for Drugs and Medical Devices